Cardiovascular
1 drug is in development for Heart Failure.
- Companies
- 1
- Clinical trials
- 95
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Heart Failure pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Omecamtiv Mecarbil | CYTOKINETICS INC (CYTK) |
About this indication
Heart Failure context
Cardiovascular·MeSH: Heart Failure (D006333)
Also known as: Cardiac Failure
Narrower concepts tracked separately: Congestive Heart Failure
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Heart Failure?
BioSniper tracks 1 drug in development for Heart Failure across 1 company.
How many clinical trials target Heart Failure?
There are 95 clinical trials targeting Heart Failure tracked by BioSniper.
What is the prevalence of Heart Failure?
The estimated prevalence of Heart Failure is approximately 1800.0 per 100,000 population.